m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0024)
Name |
Chronic pain
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: MG30
|
Full List of Target Gene(s) of This m6A-centered Disease Response
Methylcytosine dioxygenase TET1 (TET1)
In total 2 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | Downregulated spinal cord METTL3 coordinating with YTHDF2 contributes to the modulation of inflammatory pain through stabilizing upregulation of Methylcytosine dioxygenase TET1 (TET1) in spinal neurons. | |||
Responsed Disease | Chronic pain [ICD-11: MG30] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Down regulation | |||
Experiment 2 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | Downregulated spinal cord METTL3 coordinating with YTHDF2 contributes to the modulation of inflammatory pain through stabilizing upregulation of Methylcytosine dioxygenase TET1 (TET1) in spinal neurons. | |||
Responsed Disease | Chronic pain [ICD-11: MG30] | |||
Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
Target Regulation | Down regulation | |||
mmu-miR-365-3p
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [2] | |||
Response Summary | METTL3 positively modulated the mmu-miR-365-3p processing in a microprocessor protein DiGeorge critical region 8-dependent manner.METTL3-mediated m6A modification in nociceptive sensitization and provide a novel perspective on m6A modification in the development of Inflammatory pain. | |||
Responsed Disease | Chronic pain [ICD-11: MG30] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | MicroRNAs in cancer | hsa05206 | ||
Cell Process | RNA stability | |||
References